Letter to the Editor
Re: Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0 M) and gadoterate meglumine (0.5 M) at 0.1 mmol Gd/kg body weight in a clinical setting

https://doi.org/10.1016/j.ejrad.2012.04.015Get rights and content

Section snippets

Conflict of interest

I hereby declare the following: I currently have a conflict of interest as I am employed by Guerbet.

References (2)

  • N. Anzalone et al.

    Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0 M) and gadoterate meglumine (0.5 M) at 0.1 mmol Gd/kg body weight in a clinical setting

    Eur J Radiol

    (2011)
  • J.R. Landis et al.

    The measurement of observer agreement for categorical data

    Biometrics

    (1977)

Cited by (0)

View full text